Cell Therapeutics Inc (NASDAQ:CTIC)
CAPS Rating:
The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.
RSS Headlines
Fool UK
Recs
Keep Bashing CTIC 65 times in 6 months means you are trying to manipulate the stock your buddies must be real short!